Table 4.

 Costs and effects based on various scenarios

	With angiographic follow up			Without angiographic follow up
	Sirolimus stent (n = 120)	Bare stent (n = 118)	Difference	Sirolimus stent (n = 120)	Bare stent (n = 118)	Difference
Clinical events
Death	1.7%	1.7%	0	1.7%	1.7%	0
Myocardial infarction	3.3%	5.1%	−1.8%	3.3%	5.1%	−1.8
Target lesion revascularisations	0.8%	23.6%	−22.8%	0.8%	11.8%	−11
Surgical	0.8%	0.8%	0	0.8%	0.3%	0.5
Percutaneous	0.0%	22.9%	−22.9%	0.0	11.5%	−11.5
MACE-free survival	94.2%	71.2%	23.0%	94.2%	83.1%	11.1%
95% CI	89.9 to 98.4	62.9 to 79.4	13.7 to 32.2	88.9 to 97.5	64.2 to 90.9	1.7 to 28.0
Angiography	8.3%	10.2%	−1.9%	10.3%	14.1%	−3.8%
Total direct medical cost (€)	9969	9915	54	8065	7899	166
95% CI	8910 to 10504	8722 to 10449	−1054 to 1296	7052 to 9463	6821 to 9591	−1376 to 1487

MACE, major adverse cardiac events.